Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Tripartite Motif Containing 63 (TRIM63) (C-Term) Peptid

TRIM63 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5513428

Kurzübersicht für Tripartite Motif Containing 63 (TRIM63) (C-Term) Peptid (ABIN5513428)

Target

TRIM63 (Tripartite Motif Containing 63 (TRIM63))

Spezies

Human

Quelle

  • 8
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Sequenz

    TIITQLEDSR RVTKENSHQV KEELSQKFDT LYAILDEKKS ELLQRITQEQ

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-TRIM63 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    TRIM63 (Tripartite Motif Containing 63 (TRIM63))

    Hintergrund

    This gene encodes a member of the RING zinc finger protein family found in striated muscle and iris. The product of this gene is an E3 ubiquitin ligase that localizes to the Z-line and M-line lattices of myofibrils. This protein plays an important role in the atrophy of skeletal and cardiac muscle and is required for the degradation of myosin heavy chain proteins, myosin light chain, myosin binding protein, and for muscle-type creatine kinase.

    Alias Symbols: TRIM63, IRF, MURF1, RNF28, SMRZ,

    Protein Size: 353

    Gen-ID

    84676

    NCBI Accession

    NM_032588, NP_115977

    UniProt

    Q969Q1
Sie sind hier:
Chat with us!